Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Decreased fibrinolytic capacity has been suggested to accelerate the process of arterial atherogenesis by facilitating thrombosis and fibrin deposition within developing atherosclerotic lesions. Type 1 plasminogen activator inhibitor (PAI-1) is the primary inhibitor of tissue-type plasminogen activa...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Schneiderman, J, Sawdey, M S, Keeton, M R, Bordin, G M, Bernstein, E F, Dilley, R B, Loskutoff, D J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1992
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC49632/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1495992/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.89.15.6998
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!